Follow The Filings

Insider trades

Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.

4,792 companies covered Latest filing Oct 6 History loaded for 108 of 4,792

  • $699M bought by 128 insiders at 87 companies
  • $1.3B sold by 80 insiders outside a trading plan
  • $1B sold by 336 insiders under 10b5-1 plans
  • 10 companies where two or more insiders bought (30 days)

Biggest buys

Past week · by insider, all their filings added up

  1. LENLennar Corporation
    Berkshire Hathaway Inc.10% owner · +1 joint filer
    3,079,047 shares at $80.06 Sep 28–Oct 2 · 2 filings 3 superinvestors bought in Q2
    $247M
  2. KODKodiak Sciences Inc
    Baker Bros. Advisors LPDirector · +5 joint filers
    1,941,755 shares at $80.85 Sep 28–29 · 3 filings +11% to stake 1 superinvestor sold in Q2
    $157M
  3. UUUUniversal Safety Products, Inc.
    Milton C Ault IIIDirector
    18,000 shares at $5,134.00 Sep 30 +1.6% to stake
    $92.4M
  4. GPIGroup 1 Automotive, Inc.
    Conifer Management, L.L.C.10% owner
    273,712 shares at $242.15 Sep 28–30 +17% to stake 2 superinvestors bought in Q2
    $66.3M
  5. CRBGCorebridge Financial Inc.
    Life Insurance Co Nippon10% owner
    1,830,178 shares at $33.85 Sep 28–Oct 2 · 5 filings +1.5% to stake 2 superinvestors bought in Q2
    $62M
  6. GMEGameStop Corporation
    Ryan CohenCEO
    700,000 shares at $24.41 Oct 2 +1.7% to stake
    $17.1M
  7. AVRAnteris Technologies Global Corp.
    L1 Capital Pty Ltd10% owner
    1,282,035 shares at $7.59 Sep 30–Oct 5 · 2 filings +11% to stake
    $9.7M
  8. BORRBorr Drilling Limited
    Tor Olav TroimDirector
    1,500,000 shares at $4.13 Oct 5 +4.9% to stake
    $6.2M
  9. PAMPampa Energia S.A.
    Damian Miguel MindlinVicepresident
    1,432,197 shares at $3.89 Sep 28
    $5.6M
  10. GPUSHyperscale Data, Inc.
    Milton C Ault IIIChair · +1 joint filer
    10.3M shares at $0.4900 Sep 29–30
    $5.1M

Biggest sales

Past week · by insider, all their filings added up · planned sales marked

  1. MDLNMedline Inc.
    GIC Private Ltd10% owner · +2 joint filers
    20.7M shares at $34.90 Oct 2–6
    $722M
  2. THTarget Hospitality Corp.
    TDR Capital II Investments LP10% owner · +9 joint filers
    11M shares at $18.40 Oct 1 40% of stake
    $202M
  3. ESTCElastic N.V.
    Steven SchuurmanDirector
    1,500,000 shares at $90.13 Oct 5 25% of stake
    $135M
  4. NBISNebius Group N.V.
    Ophir NaveCOO
    500,000 shares at $235.53 Oct 5 52% of stake Planned sale (10b5-1)
    $118M
  5. CBRSCerebras Systems Inc.
    Dhiraj MallickCOO
    396,000 shares at $204.04 Sep 29 100% of stake Planned sale (10b5-1)
    $80.8M
  6. CRWDCrowdStrike Holdings, Inc.
    Michael SentonasPresident
    241,944 shares at $265.45 Sep 30 16% of stake Planned sale (10b5-1)
    $64.2M
  7. AAPLApple Inc Com
    Timothy D CookChair
    191,753 shares at $332.96 Oct 2 5.5% of stake Planned sale (10b5-1)
    $63.8M
  8. MPWRMonolithic Power Systems, Inc.
    Michael HsingCEO
    30,000 shares at $1,344.97 Sep 28 3.5% of stake Planned sale (10b5-1)
    $40.3M
  9. ACTEnact Holdings, Inc.
    Genworth Holdings, Inc.10% owner
    762,894 shares at $48.65 Sep 30 0.7% of stake
    $37.1M
  10. WDAYWorkday, Inc.
    David A Duffield10% owner
    197,417 shares at $187.81 Sep 28–Oct 1 · 2 filings 65% of stake Planned sale (10b5-1)
    $37.1M

Cluster buying

Companies where two or more insiders bought on the open market in the last 30 days · most buyers first

  1. TSMTaiwan Semiconductor Mfg Ltd 21 insiders · $86K

    Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more

    Latest buy Sep 7 21 executives 20 superinvestors sold in Q2
  2. SPGSimon Property Group, Inc. 11 insiders · $461K

    Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more

    Latest buy Sep 30
  3. SBLKStar Bulk Carriers Corp. 7 insiders · $4.8M

    Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more

    Latest buy Sep 15 3 executives 1 superinvestor bought in Q2
  4. FULH. B. Fuller Company 7 insiders · $621K

    Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more

    Latest buy Sep 30 1 superinvestor bought in Q2
  5. RWTRedwood Trust, Inc. 6 insiders · $969K

    Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more

    Latest buy Sep 21 5 executives
  6. MPBMid Penn Bancorp 6 insiders · $32K

    Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more

    Latest buy Sep 30 1 executive
  7. GMEGameStop Corporation 5 insiders · $76.4M

    Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more

    Latest buy Oct 2 1 executive
  8. PMTSCPI Card Group Inc. 5 insiders · $12M

    Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more

    Latest buy Sep 14 1 executive
  9. XBPXBP Global Holdings, Inc. 5 insiders · $2.4M

    Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more

    Latest buy Sep 15 2 executives
  10. BWFGBankwell Financial Group, Inc. 5 insiders · $435K

    Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more

    Latest buy Sep 8

All insider trades

Newest filings first · one row per filing · every open-market buy and sale

  1. Michael N Intrator CEO
    CRWVCoreWeave, Inc.
    Planned sale
    $26.7M 307,692 shares at $86.65
    Traded Sep 29 Filed Oct 1
  2. Rami Rahim EVP, Pres GM Networking
    HPEHewlett Packard Enterprise Company
    Planned sale
    $2.1M 34,456 shares at $61.42 3.8% of stake
    Traded Sep 29 Filed Oct 1
  3. Phillip Anson Nickerson Vice President of Exploration
    SBMTSilver Bow Mining Corp.
    Buy
    $4,430 500 shares at $8.86 +2.3% to stake
    Traded Sep 29 Filed Oct 1
  4. Jennifer Newstead SVP, GC and Government Affairs
    AAPLApple Inc Com
    Planned sale
    $806K 2,399 shares at $336.18 5.4% of stake
    Traded Sep 29 Filed Oct 1
  5. Steve Ladd Huffman CEO
    RDDTReddit, Inc.
    Planned sale
    $2.5M 17,308 shares at $144.87 4.9% of stake
    Traded Sep 29 Filed Oct 1
  6. Alan B. Sandler Chief Development Officer
    RVMDRevolution Medicines, Inc.
    Planned sale
    $1.3M 6,309 shares at $202.14 11% of stake
    Traded Sep 29 Filed Oct 1
  7. August J. Troendle CEO
    MEDPMedpace Holdings, Inc.
    Sale
    $30.3M 48,667 shares at $623.03 13% of stake
    Traded Sep 29–30 Filed Oct 1
  8. Brian J Roney CEO
    PRHIPresurance Holdings, Inc.
    Buy
    $51K 7,500 shares at $6.75 +10% to stake
    Traded Sep 30 Filed Oct 1
  9. Donna Roberts SVP, Chief HR Officer
    CBRLCracker Barrel Old Country Store, Inc.
    Sale
    $182K 3,500 shares at $52.08 7.4% of stake
    Traded Oct 1 Filed Oct 1
  10. Jeffrey Bertolini COO
    CARLCarlsmed, Inc.
    Planned sale
    $3,400 243 shares at $13.99 1.1% of stake
    Traded Sep 30 Filed Oct 1
  11. Harold J Meloche CFO
    PRHIPresurance Holdings, Inc.
    Buy
    $26K 4,100 shares at $6.38 +40% to stake
    Traded Sep 30 Filed Oct 1
  12. Paul A Mahon EVP & General Counsel
    UTHRUnited Therapeutics Corporation
    Planned sale
    $4.7M 8,300 shares at $564.95 16% of stake
    Traded Oct 1 Filed Oct 1
  13. Cesar Nivaldo Gon CEO
    CINTCI&T Inc
    Buy
    $20K 6,684 shares at $3.01 +8.9% to stake
    Traded Sep 29–30 Filed Oct 1
  14. Neto Bruno Guicardi Pres. of N. Am. /Europe Ops
    CINTCI&T Inc
    Buy
    $8,410 2,825 shares at $2.98 +2.9% to stake
    Traded Sep 29–30 Filed Oct 1
  15. Martine A Rothblatt CEO
    UTHRUnited Therapeutics Corporation
    Planned sale
    $1.1M 1,920 shares at $550.22 0.6% of stake
    Traded Sep 30 Filed Oct 1
  16. Martine A Rothblatt CEO
    UTHRUnited Therapeutics Corporation
    Planned sale
    $3.9M 7,580 shares at $517.97 2.3% of stake
    Traded Sep 30 Filed Oct 1
  17. Nello Mainolfi CEO
    KYMRKymera Therapeutics, Inc.
    Planned sale
    $3.4M 30,000 shares at $113.80 4.3% of stake
    Traded Oct 1 Filed Oct 1
  18. Matthew Barnes President - Foot Locker Intl
    DKSDick's Sporting Goods Inc
    Buy
    $500K 3,665 shares at $136.39 +44% to stake
    Traded Sep 30 Filed Oct 1
  19. Chi Fung Cheng Chief Technology Officer
    CRDOCredo Technology Group Holding Ltd
    Planned sale
    $5.3M 27,500 shares at $193.93 0.5% of stake
    Traded Sep 29 Filed Oct 1
  20. William Staples CEO
    GTLBGitLab Inc.
    Buy
    $125K 2,677 shares at $46.62 +0.4% to stake
    Traded Sep 30 Filed Oct 1
  21. Robert D Vilsack Secretary & CLO
    PKOHPark-Ohio Holdings Corp.
    Planned sale
    $90K 1,941 shares at $46.54 1.3% of stake
    Traded Sep 30 Filed Oct 1
  22. Ryan M. Daniels SVP, Wood Products
    RYNRayonier Inc.
    Planned sale
    $16K 887 shares at $18.56 1.6% of stake
    Traded Sep 30 Filed Oct 1
  23. George Kurian CEO
    NTAPNetApp, Inc.
    Planned sale
    $10.5M 50,000 shares at $209.95 19% of stake
    Traded Sep 29 Filed Oct 1
  24. Haim Chera EVP - Head of Retail
    VNOVornado Realty Trust
    Sale
    $3.1M 90,000 shares at $34.01 45% of stake
    Traded Sep 29 Filed Oct 1
  25. Cheryl Gault COO
    RAPPRapport Therapeutics, Inc.
    Planned sale
    $332K 10,000 shares at $33.19 6.7% of stake
    Traded Sep 30 Filed Oct 1
  26. Tobin W Juvenal Chief Commercial Officer
    CSTLCastle Biosciences, Inc.
    Planned sale
    $232K 6,577 shares at $35.29 11% of stake
    Traded Sep 29–30 Filed Oct 1
  27. Robert D Vilsack Secretary & CLO
    PKOHPark-Ohio Holdings Corp.
    Planned sale
    $355K 7,640 shares at $46.41 4.7% of stake
    Traded Sep 29–30 Filed Oct 1
  28. Matthew J Cox CEO
    MATXMatson, Inc.
    Planned sale
    $2.2M 10,000 shares at $222.33 4.4% of stake
    Traded Sep 29 Filed Oct 1
  29. Tammy L Martin General Counsel and Secretary
    CTMCastellum, Inc.
    Buy
    $747 1,396 shares at $0.5400 +9.3% to stake
    Traded Oct 1 Filed Oct 1
  30. Glen R Ives CEO
    CTMCastellum, Inc.
    Buy
    $910 1,700 shares at $0.5400 +0.8% to stake
    Traded Oct 1 Filed Oct 1
  31. Atul Dandekar Csbo
    MAZEMaze Therapeutics, Inc.
    Planned sale
    $203K 7,500 shares at $27.06 19% of stake
    Traded Sep 29 Filed Oct 1
  32. Mei Kanayama Representative Director (PEO)
    TKLFTokyo Lifestyle Co., Ltd.
    Buy
    $383K 1,396,755 shares at $0.2700 +19% to stake
    Traded Sep 29 Filed Oct 1
  33. Derek Gordon Schiller EVP, Business
    BATRKAtlanta Braves Holdings, Inc.
    Planned sale
    $9.3M 175,395 shares at $53.20 36% of stake
    Traded Sep 30 Filed Oct 1
  34. Gregory John Heller EVP, CLO & Secretary
    BATRKAtlanta Braves Holdings, Inc.
    Planned sale
    $4.3M 80,263 shares at $53.89 78% of stake
    Traded Sep 29 Filed Oct 1
  35. Matthew M. Kim Comptroller
    SOSouthern Company (The)
    Planned sale
    $8,273 100 shares at $82.73 2% of stake
    Traded Oct 1 Filed Oct 1
  36. Robert D Vilsack Secretary & CLO
    PKOHPark-Ohio Holdings Corp.
    Planned sale
    $306K 6,497 shares at $47.11 3.9% of stake
    Traded Sep 29 Filed Oct 1
  37. Alejandro Gustavo Elsztain CEO
    CRESYCresud S.A.C.I.F. y A.
    Buy
    $199K 17,334 shares at $11.50 +1.4% to stake
    Traded Sep 30–Oct 1 Filed Oct 1
  38. Scott Mezvinsky CEO
    YUMYum! Brands, Inc.
    Planned sale
    $33K 241 shares at $136.89 100% of stake
    Traded Oct 1 Filed Oct 1
  39. Francisco Gonzalez CFO
    SKYHSky Harbour Group Corporation
    Buy
    $15K 1,500 shares at $9.69 +0.2% to stake
    Traded Sep 30 Filed Oct 1
  40. Stuart A Rose Executive COB
    REXREX American Resources Corporation
    Sale
    $2.1M 50,000 shares at $42.55 2.1% of stake
    Traded Sep 30 Filed Oct 1
  41. Thomas Patrick Kelly CFO
    XENEXenon Pharmaceuticals Inc.
    Buy
    $560K 15,000 shares at $37.32 New stake
    Traded Sep 30 Filed Oct 1
  42. Ian Mortimer CEO
    XENEXenon Pharmaceuticals Inc.
    Buy
    $1.1M 30,000 shares at $37.38 +151% to stake
    Traded Sep 30 Filed Oct 1
  43. Richard Barry CEO
    FLNAFilana Therapeutics, Inc.
    Buy
    $278K 306,813 shares at $0.9100 +30% to stake
    Traded Sep 29–30 Filed Oct 1
  44. Kun Dai CEO
    UXINUxin Limited
    Buy
    $9,945 7,443 shares at $1.34 +88% to stake
    Traded Sep 30 Filed Oct 1
  45. Milton C Ault III Chair · +1 joint filer
    GPUSHyperscale Data, Inc.
    Buy
    $5.1M 10.3M shares at $0.4900
    Traded Sep 29–30 Filed Oct 1
  46. Yanjun Wang CCO and GC
    SESea Limited
    Planned sale
    $196K 2,000 shares at $98.05 2.2% of stake
    Traded Sep 29–30 Filed Oct 1
  47. Cobian Mauricio Doehner EVP Corporate Affairs
    CXCemex S.A.B. de C.V.
    Sale
    $8.9M 927,900 shares at $9.57 61% of stake
    Traded Sep 30 Filed Sep 30
  48. George Kurtz CEO
    CRWDCrowdStrike Holdings, Inc.
    Planned sale
    $5.2M 20,000 shares at $258.20 0.3% of stake
    Traded Sep 28–29 Filed Sep 30

About this data

  • Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
  • Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
  • A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
  • Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
  • We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.